Wang Hong, He Dongsheng
Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Histol Histopathol. 2023 Dec;38(12):1475-1486. doi: 10.14670/HH-18-610. Epub 2023 Mar 20.
Lung adenocarcinoma remains one of the most significant threats to human life as it involves multiple etiologies, including alteration of oncogenes or tumor-inhibitory genes. Long non-coding RNAs (lncRNAs) have been reported to have both cancer promoting and cancer inhibiting effects. In this work, we investigated the function and mechanism of lncRNA LINC01123 in lung adenocarcinoma.
The expression of LINC01123, miR-4766-5p, and PYCR1 (pyrroline-5-carboxylate reductase 1) mRNA was analyzed by RT-qPCR. The protein expression levels of PYCR1 and the apoptosis-related proteins (Bax and Bcl-2) were determined by western blotting. Cell proliferation and migration were determined by CCK-8 and wound-healing assays, respectively. Tumor growth in nude mice and Ki67 immunohistochemical staining were used to determine the in vivo role of LINC01123. The putative binding relationships miR-4766-5p has with LINC01123 and PYCR1, which had been identified by analysis of public databases, were validated through RIP and dual-luciferase reporter assays.
LINC01123 and PYCR1 overexpression and miR-4766-5p downregulation were shown to occur in lung adenocarcinoma samples. LINC01123 depletion repressed lung adenocarcinoma cell growth and migration and blocked the development of solid tumors in an animal model. Moreover, LINC01123 bound directly to miR-4766-5p, the downregulation of which attenuated the anticancer effects of LINC01123 depletion in lung adenocarcinoma cells. MiR-4766-5p directly targeted downstream PYCR1 to suppress PYCR1 expression. The repressive effects of PYCR1 knockdown on the migration and proliferation of lung adenocarcinoma cells were also partly abolished by miR-4766-5p downregulation.
Downregulation of LINC01123 represses lung adenocarcinoma progression. This suggests that LINC01123 functions as an oncogenic driver in lung adenocarcinoma by controlling the miR-4766-5p/PYCR1 axis.
肺腺癌仍然是对人类生命的重大威胁之一,因为它涉及多种病因,包括癌基因或肿瘤抑制基因的改变。据报道,长链非编码RNA(lncRNA)具有促进癌症和抑制癌症的作用。在这项研究中,我们调查了lncRNA LINC01123在肺腺癌中的功能和机制。
通过RT-qPCR分析LINC01123、miR-4766-5p和PYCR1(吡咯啉-5-羧酸还原酶1)mRNA的表达。通过蛋白质印迹法测定PYCR1和凋亡相关蛋白(Bax和Bcl-2)的蛋白表达水平。分别通过CCK-8和伤口愈合试验测定细胞增殖和迁移。利用裸鼠体内肿瘤生长和Ki67免疫组化染色来确定LINC01123在体内的作用。通过RIP和双荧光素酶报告基因试验验证了通过公共数据库分析确定的miR-4766-5p与LINC01123和PYCR1之间的推定结合关系。
肺腺癌样本中显示出LINC01123和PYCR1的过表达以及miR-4766-5p的下调。LINC01123的缺失抑制了肺腺癌细胞的生长和迁移,并在动物模型中阻断了实体瘤的发展。此外,LINC01123直接与miR-4766-5p结合,miR-4766-5p的下调减弱了LINC01123缺失对肺腺癌细胞的抗癌作用。MiR-4766-5p直接靶向下游的PYCR1以抑制PYCR1的表达。miR-4766-5p的下调也部分消除了PYCR1敲低对肺腺癌细胞迁移和增殖的抑制作用。
LINC01123的下调抑制肺腺癌进展。这表明LINC01123通过控制miR-4766-5p/PYCR1轴在肺腺癌中作为致癌驱动因子发挥作用。